肝転移治療の世界市場レポート 2025年

肝転移治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.5％で23億7,000万米ドルに成長します。予測期間の成長は、患者中心のケアモデル、精密医療、外来・外来医療へのシフト、規制イニシアチブに起因すると考えられます。予測期間における主な動向には、次世代シーケンシング技術、免疫腫瘍学の進歩、リキッドバイオプシー技術の出現、補助療法などがあります。

肝疾患の罹患率の増加は、当面の肝転移治療市場の拡大を牽引すると予測されます。肝疾患には、肝臓の機能を損なうさまざまな障害が含まれ、代謝や解毒などの身体機能や健康全般にリスクをもたらします。肝転移の治療は、肝機能と全身の健康を維持する上で重要な役割を果たします。多くの場合、長期的な寛解を得るためには、外科的切除、アブレーション技術、または標的治療を含む包括的治療が必要であり、多くの場合、化学療法や免疫療法などの全身薬物療法によって補完されます。例えば、Cancer Australiaは、2022年にオーストラリアで新たに診断される肝臓がんの症例は約2,905例であると報告しており、この疾患の負担が大きいことを示しています。85歳までに肝臓がんを発症するリスクが予測されることから、肝臓疾患に効果的に対処することの重要性が強調されています。このように、肝臓疾患の有病率の増加は、肝転移治療市場の主要な促進要因となっています。

肝転移治療市場の主要企業は、効果的で利便性の高い治療オプションを提供するため、肝臓指向性治療の導入に注力しています。肝臓指向性療法は、特に肝臓関連の疾患や病態を標的とし、肝臓内のがん細胞を直接標的とすることで肝転移の管理を支援します。これらの治療法には、外科的切除、ラジオ波焼灼療法、経動脈的化学塞栓療法、ラジオ波塞栓療法、定位体放射線療法など、さまざまなアプローチがあります。例えば、デルキャス・システムズ・インコーポレイテッドは2023年8月、肝臓の50％未満に影響を及ぼす転移性ブドウ膜黒色腫の成人患者を対象とした肝臓指向性治療であるHepzatoキットを発売しました。このキットは、化学療法剤であるメルファランをデルカスの肝デリバリーシステムを通じて肝臓に直接投与するもので、全身毒性を最小限に抑えながら標的治療を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界肝転移治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の肝転移治療市場：成長率分析
• 世界の肝転移治療市場の実績：規模と成長, 2019-2024
• 世界の肝転移治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界肝転移治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肝転移治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 標的療法
• 免疫療法
• 世界の肝転移治療市場原発性がん、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大腸がん
• 乳がん
• 世界の肝転移治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 専門薬局
• 世界の肝転移治療市場化学療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞傷害性化学療法
• 術前化学療法
• 補助化学療法
• 世界の肝転移治療市場標的療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• チロシンキナーゼ阻害剤（TKI）
• モノクローナル抗体
• MTOR阻害剤
• 世界の肝転移治療市場免疫療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫チェックポイント阻害剤
• がんワクチン
• 養子細胞移植療法

第7章 地域別・国別分析

• 世界の肝転移治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の肝転移治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肝転移治療市場：競合情勢
• 肝転移治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Novartis AG
• Bristol Myers Squibb
• AstraZeneca plc
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim
• Gilead Sciences Inc.
• Takeda Pharmaceutical Company
• Astellas Pharma Inc.
• Daiichi Sankyo Company Ltd.
• Eisai Co. Ltd.
• Incyte Corporation
• Ipsen

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 肝転移治療市場2029：新たな機会を提供する国
• 肝転移治療市場2029：新たな機会を提供するセグメント
• 肝転移治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Liver metastases treatment involves therapeutic interventions targeted at managing cancerous growths that have spread to the liver from primary tumors elsewhere in the body. This comprehensive treatment strategy aims to improve patient outcomes by shrinking or eliminating metastatic lesions, alleviating symptoms, and enhancing overall quality of life.

The main types of liver metastases treatment include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a cancer treatment approach that utilizes drugs to destroy cancer cells. It is employed for treating liver metastasis resulting from various primary cancers such as colorectal cancer and breast cancer. Chemotherapy drugs are distributed through various channels including hospital pharmacies and specialty pharmacies.

The liver metastasis treatment market research report is one of a series of new reports from The Business Research Company that provides liver metastasis treatment market statistics, including liver metastasis treatment industry global market size, regional shares, competitors with a liver metastasis treatment market share, detailed liver metastasis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the liver metastasis treatment industry. This liver metastasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liver metastases treatment market size has grown strongly in recent years. It will grow from $1.57 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to expansion of personalized medicine, expanded access to healthcare, enhanced multidisciplinary care, clinical trials and research initiatives.

The liver metastases treatment market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to patient-centric care models, precision medicine, shift towards outpatient, ambulatory care and regulatory initiatives. Major trends in the forecast period include next-generation sequencing technologies, immuno-oncology advancements, emergence of liquid biopsy technologies and adjuvant therapies.

The increasing incidence of liver disease is anticipated to drive the expansion of the liver metastases treatment market in the foreseeable future. Liver disease encompasses various disorders that impair the liver's function, posing risks to overall health and bodily functions such as metabolism and detoxification. Treatments for liver metastases play a critical role in preserving liver function and overall wellness. In many cases, comprehensive treatments involving surgical resection, ablation techniques, or targeted therapies are necessary for achieving long-term remission, often complemented by systemic medications such as chemotherapy or immunotherapy. For example, Cancer Australia reported approximately 2,905 new cases of liver cancer diagnosed in Australia in 2022, indicating a significant burden of the disease. The predicted risk of developing liver cancer by age 85 underscores the importance of addressing liver disease effectively. Thus, the increasing prevalence of liver disease acts as a key driver for the liver metastases treatment market.

Leading companies in the liver metastases treatment market are focused on introducing liver-directed therapies to provide effective and convenient treatment options. Liver-directed therapies specifically target liver-related diseases or conditions, aiding in the management of liver metastases by directly targeting cancerous cells within the liver. These therapies encompass various approaches, including surgical resection, radiofrequency ablation, transarterial chemoembolization, radioembolization, and stereotactic body radiation therapy. For instance, Delcath Systems Incorporated launched the Hepzato kit in August 2023, a liver-directed treatment for adult patients with metastatic uveal melanoma affecting less than 50% of the liver. The kit delivers melphalan, a chemotherapeutic agent, directly to the liver through Delcath's Hepatic Delivery System, offering targeted treatment while minimizing systemic toxicity.

In August 2023, TriSalus Life Sciences completed its merger with MedTech Acquisition Corporation, underscoring its commitment to advancing innovative treatments for liver and pancreatic tumors. TriSalus Life Sciences specializes in developing proprietary delivery technologies that enable precise and targeted delivery of immunotherapy agents directly to tumor sites, maximizing therapeutic efficacy while minimizing systemic side effects. The merger with MedTech Acquisition Corporation, a blank check company, signifies a strategic move aimed at accelerating the development and commercialization of novel treatments for liver and pancreatic tumors.

Major companies operating in the liver metastases treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol Myers Squibb, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Gilead Sciences Inc., Takeda Pharmaceutical Company, Astellas Pharma Inc., Daiichi Sankyo Company Ltd., Eisai Co. Ltd., Incyte Corporation, Ipsen, Seattle Genetics, Exelixis Inc., Array BioPharma Inc., Genentech Inc., Clovis Oncology, Agios Pharmaceuticals Inc., Taiho Pharmaceutical Co.Ltd

North America was the largest region in the liver metastases treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver metastases treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liver metastases treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The liver metastases treatment market consists of revenues earned by entities by providing services such as surgery, radiotherapy, palliative care, diagnostic imaging, biopsy, ablation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver metastases treatment market also includes sales of therasphere, sir-spheres gamma-90 resin microspheres, Avastin, Nexavar, Keytruda, radiofrequency ablation devices, and cyberknife. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Metastases Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver metastases treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver metastases treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver metastases treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Chemotherapy; Targeted Therapy; Immunotherapy
• 2) By Primary Cancer: Colorectal Cancer; Breast Cancer
• 3) By Distribution Channel: Hospital Pharmacies; Specialty Pharmacies
• Subsegments:
• 1) By Chemotherapy: Cytotoxic Chemotherapy; Neoadjuvant Chemotherapy; Adjuvant Chemotherapy
• 2) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Monoclonal Antibodies; MTOR Inhibitors
• 3) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Transfer Therapy
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liver Metastases Treatment Market Characteristics

3. Liver Metastases Treatment Market Trends And Strategies

4. Liver Metastases Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Liver Metastases Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Liver Metastases Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Liver Metastases Treatment Market Growth Rate Analysis
• 5.4. Global Liver Metastases Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Liver Metastases Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Liver Metastases Treatment Total Addressable Market (TAM)

6. Liver Metastases Treatment Market Segmentation

• 6.1. Global Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• 6.2. Global Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Colorectal Cancer
• Breast Cancer
• 6.3. Global Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Specialty Pharmacies
• 6.4. Global Liver Metastases Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cytotoxic Chemotherapy
• Neoadjuvant Chemotherapy
• Adjuvant Chemotherapy
• 6.5. Global Liver Metastases Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tyrosine Kinase Inhibitors (TKIs)
• Monoclonal Antibodies
• MTOR Inhibitors
• 6.6. Global Liver Metastases Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immune Checkpoint Inhibitors
• Cancer Vaccines
• Adoptive Cell Transfer Therapy

7. Liver Metastases Treatment Market Regional And Country Analysis

• 7.1. Global Liver Metastases Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Liver Metastases Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Metastases Treatment Market

• 8.1. Asia-Pacific Liver Metastases Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Metastases Treatment Market

• 9.1. China Liver Metastases Treatment Market Overview
• 9.2. China Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Metastases Treatment Market

• 10.1. India Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Metastases Treatment Market

• 11.1. Japan Liver Metastases Treatment Market Overview
• 11.2. Japan Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Metastases Treatment Market

• 12.1. Australia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Metastases Treatment Market

• 13.1. Indonesia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Metastases Treatment Market

• 14.1. South Korea Liver Metastases Treatment Market Overview
• 14.2. South Korea Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Metastases Treatment Market

• 15.1. Western Europe Liver Metastases Treatment Market Overview
• 15.2. Western Europe Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Metastases Treatment Market

• 16.1. UK Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Metastases Treatment Market

• 17.1. Germany Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Metastases Treatment Market

• 18.1. France Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Metastases Treatment Market

• 19.1. Italy Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Metastases Treatment Market

• 20.1. Spain Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Metastases Treatment Market

• 21.1. Eastern Europe Liver Metastases Treatment Market Overview
• 21.2. Eastern Europe Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Metastases Treatment Market

• 22.1. Russia Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Metastases Treatment Market

• 23.1. North America Liver Metastases Treatment Market Overview
• 23.2. North America Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Metastases Treatment Market

• 24.1. USA Liver Metastases Treatment Market Overview
• 24.2. USA Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Metastases Treatment Market

• 25.1. Canada Liver Metastases Treatment Market Overview
• 25.2. Canada Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Metastases Treatment Market

• 26.1. South America Liver Metastases Treatment Market Overview
• 26.2. South America Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Metastases Treatment Market

• 27.1. Brazil Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Metastases Treatment Market

• 28.1. Middle East Liver Metastases Treatment Market Overview
• 28.2. Middle East Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Metastases Treatment Market

• 29.1. Africa Liver Metastases Treatment Market Overview
• 29.2. Africa Liver Metastases Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Liver Metastases Treatment Market, Segmentation By Primary Cancer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Liver Metastases Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Metastases Treatment Market Competitive Landscape And Company Profiles

• 30.1. Liver Metastases Treatment Market Competitive Landscape
• 30.2. Liver Metastases Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Liver Metastases Treatment Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Novartis AG
• 31.4. Bristol Myers Squibb
• 31.5. AstraZeneca plc
• 31.6. Eli Lilly and Company
• 31.7. Amgen Inc.
• 31.8. Boehringer Ingelheim
• 31.9. Gilead Sciences Inc.
• 31.10. Takeda Pharmaceutical Company
• 31.11. Astellas Pharma Inc.
• 31.12. Daiichi Sankyo Company Ltd.
• 31.13. Eisai Co. Ltd.
• 31.14. Incyte Corporation
• 31.15. Ipsen

32. Global Liver Metastases Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Metastases Treatment Market

34. Recent Developments In The Liver Metastases Treatment Market

35. Liver Metastases Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Liver Metastases Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Liver Metastases Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Liver Metastases Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer